Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details Narrative)

v3.22.1
Stockholders’ Equity (Details Narrative)
1 Months Ended 3 Months Ended 12 Months Ended
Mar. 31, 2022
USD ($)
$ / shares
shares
Feb. 16, 2022
$ / shares
shares
Jan. 03, 2022
$ / shares
shares
Mar. 26, 2021
shares
Mar. 31, 2022
USD ($)
$ / shares
shares
Feb. 28, 2022
$ / shares
shares
Mar. 31, 2021
USD ($)
$ / shares
shares
Feb. 28, 2021
shares
Jan. 31, 2021
USD ($)
$ / shares
shares
Jan. 31, 2020
$ / shares
shares
Mar. 31, 2022
USD ($)
$ / shares
shares
Mar. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2021
$ / shares
shares
Mar. 25, 2021
shares
Subsidiary, Sale of Stock [Line Items]                            
Common stock issued during period                 1,711,783          
Share price per share | $ / shares                 $ 3.00          
Proceeds from public offering | $                 $ 4,532,445          
Warrants to purchase shares of common stock       2,190,000         136,943          
Warrant exercise price | $ / shares                 $ 3.75          
Number of shares, warrants exercised                       495,641  
Common stock, shares authorized 24,000,000     24,000,000 24,000,000   12,000,000       24,000,000 12,000,000 24,000,000 12,000,000
Warrants exercisable date       May 24, 2021                    
Preferred stock, shares authorized 10,000,000       10,000,000           10,000,000   10,000,000  
Preferred stock, par value | $ / shares $ 0.001       $ 0.001           $ 0.001   $ 0.001  
Preferred stock, shares issued 465       465           465   465  
Preferred stock, shares outstanding 465       465           465   465  
Number of shares granted                     162,000   698,831  
Allocation share based compensation expense | $                     $ 170,976 $ 117,477    
Options exercise price | $ / shares                     $ 2.04      
Stock options compensation cost | $ $ 1,222,243       $ 1,222,243           $ 1,222,243      
Weighted average remaining recognition period                     1 year 11 months 8 days      
Directors [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Number of shares granted         56,000                  
Option strike price | $ / shares $ 2.50       $ 2.50           $ 2.50      
Stock option grant percentage                     25.00%      
Stock option remaining grant percentage                     75.00%      
Four Employees [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Number of shares granted                     22,000      
President and CEO [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Number of shares granted           70,000                
Option strike price | $ / shares           $ 2.50                
Options exercise price | $ / shares   $ 2.50                        
Common shares granted for the period   30,000                        
Two Consultants [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Number of shares granted         14,000                  
Option strike price | $ / shares $ 2.50       $ 2.50           $ 2.50      
Stock option grant percentage                     50.00%      
Stock option remaining grant percentage                     50.00%      
Consultant [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Stock option grant percentage 50.00%                          
Stock option remaining grant percentage 50.00%                          
Vesting date Jun. 30, 2022       Jun. 30, 2022                  
Options exercise price | $ / shares $ 2.50                          
Common shares granted for the period 3,000                          
Eleven Employees [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Options exercise price | $ / shares     $ 1.87                      
Common shares granted for the period     12,033                      
2013 Stock Option Plan [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Common stock shares reserved for issuance 187,762       187,762           187,762      
2020 Stock Appreciation Rights Plan [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Options exercise price | $ / shares                     $ 2.04      
Weighted average remaining recognition period                     2 years 2 months 15 days      
Number of shares granted                     12,033      
Unrecognized share based compensation cost | $ $ 660,001       $ 660,001           $ 660,001      
Investor [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Share price per share | $ / shares             $ 4.99         $ 4.99    
Stock issued during the period, service rendered             1,500              
April 2020 Offering [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Common stock issued during period             21,591              
Number of shares, warrants exercised             191,204              
Placement Agent Warrants [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Warrant exercise price | $ / shares             $ 5.55625         $ 5.55625    
Placement Agent Warrants [Member] | Measurement Input, Share Price [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Percentage of warrant exercise price             1.25         1.25    
Common Stock [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Common stock issued during period                       3,901,783    
Stock issued during the period, service rendered                       1,500    
Common Stock [Member] | Placement Agent Warrants [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Warrants to purchase shares of common stock             175,200         175,200    
Percentage of warrant exercise price             0.08         0.08    
Common Stock [Member] | Placement Agent Warrants [Member] | Measurement Input, Share Price [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Percentage of warrant exercise price             8.0         8.0    
Series D Convertible Preferred Stock [Member] | Common Stock [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Conversion of stock shares converted             250              
Number of shares as in-kind payment, shares             19,000              
Series D Preferred Stock [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Common stock issued during period         87,267                  
Preferred stock, shares outstanding 132       132           132      
Series D Preferred Stock [Member] | Institutional Securities Purchase Agreement [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Preferred stock, par value | $ / shares                   $ 1,000        
Sale of shares                   1,640        
Dividend percentage                   9.00%        
Conversion price per share | $ / shares                   $ 2.50        
Conversion description                   Alternatively, a holder may at any time convert all, or any part, of its Series D Preferred Shares at an alternative conversion price equal to the lower of the applicable conversion price then in effect, and the greater of (x) $1.80 and (y) 85% of the average volume weighted average price (“VWAP”) of the Common Stock for a five (5) trading day period prior to such conversion. Upon the occurrence of certain triggering events, described in the Certificate of Designations, including, but not limited to payment defaults, breaches of transaction documents, failure to maintain listing on the Nasdaq Capital Market, and other defaults set forth therein, the Series D Preferred Shares would become subject to redemption, at the option of a holder, at a 125% premium to the underlying value of the Series D Preferred Stock being redeemed        
Series E Preferred Stock [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Common stock issued during period         61,651                  
Series E Preferred Stock [Member] | Other Securities Purchase Agreement [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Conversion of stock shares converted         48,544                  
Preferred stock, par value | $ / shares $ 1,000       $ 1,000           $ 1,000      
Sale of shares         333                  
Dividend percentage         9.00%                  
Private Placement [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Common stock issued during period             119,000 263,200            
Private Placement [Member] | Purchase Agreement [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Warrants to purchase shares of common stock             2,190,000         2,190,000    
Warrant exercise price | $ / shares             $ 4.32         $ 4.32    
Public Offering [Member]                            
Subsidiary, Sale of Stock [Line Items]                            
Common stock issued during period             2,190,000              
Share price per share | $ / shares             $ 4.445         $ 4.445    
Proceeds from public offering | $             $ 8,736,487